UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Kenvue Inc. (NYSE:KVUE – Free Report) by 0.8% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 17,663,555 shares of the company’s stock after acquiring an additional 148,628 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Kenvue were worth $337,551,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of KVUE. BlackRock Inc. purchased a new stake in Kenvue in the second quarter valued at approximately $2,882,279,000. State Street Corp boosted its holdings in shares of Kenvue by 3.5% in the 4th quarter. State Street Corp now owns 118,865,134 shares of the company’s stock valued at $2,050,424,000 after purchasing an additional 4,063,257 shares during the last quarter. Pentwater Capital Management LP acquired a new position in shares of Kenvue in the 2nd quarter valued at $977,094,000. Geode Capital Management LLC grew its stake in shares of Kenvue by 0.8% during the 4th quarter. Geode Capital Management LLC now owns 49,862,574 shares of the company’s stock valued at $856,778,000 after buying an additional 371,322 shares during the period. Finally, Independent Franchise Partners LLP grew its stake in shares of Kenvue by 56.3% during the 4th quarter. Independent Franchise Partners LLP now owns 48,146,476 shares of the company’s stock valued at $830,527,000 after buying an additional 17,343,785 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.
Analysts Set New Price Targets
A number of brokerages recently weighed in on KVUE. Wall Street Zen cut Kenvue from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Weiss Ratings upgraded Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 15th. Barclays raised their price objective on Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 21st. Zacks Research lowered Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 7th. Finally, UBS Group decreased their target price on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Tuesday, August 11th. Three analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $19.27.
Kenvue Stock Down 1.4%
Shares of Kenvue stock opened at $18.90 on Tuesday. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $20.82. The stock has a market cap of $36.30 billion, a price-to-earnings ratio of 21.72, a price-to-earnings-growth ratio of 1.37 and a beta of 0.47. The company has a current ratio of 1.01, a quick ratio of 0.71 and a debt-to-equity ratio of 0.67. The company has a fifty day moving average price of $19.18 and a 200 day moving average price of $18.25.
Kenvue (NYSE:KVUE – Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.31 EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The company had revenue of $3.96 billion for the quarter, compared to analyst estimates of $3.97 billion. During the same quarter in the prior year, the firm earned $0.29 EPS. The company’s revenue for the quarter was up 3.0% compared to the same quarter last year. Equities research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.
Kenvue Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 26th. Shareholders of record on Wednesday, August 12th were given a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 4.4%. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend was Wednesday, August 12th. Kenvue’s dividend payout ratio is 96.55%.
About Kenvue
Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.
The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.
See Also
- Five stocks we like better than Kenvue
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE – Free Report).
Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.
